Miller, Amanda K <br/><br/>
PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Dec 2011 
 - 5761-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.05391-11  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--pharmacology<br/>Bacterial Proteins--genetics<br/>Colistin--pharmacology<br/>Cystic Fibrosis--drug therapy<br/>Drug Resistance, Bacterial--genetics<br/>Female<br/>Humans<br/>Lipid A--chemistry<br/>Male<br/>Microbial Sensitivity Tests<br/>Mutation<br/>Polymyxins--pharmacology<br/>Pseudomonas Infections--drug therapy<br/>Pseudomonas aeruginosa--drug effects